As the FDA’s top biologics official, Peter Marks oversaw regulation of cell and gene therapies. The departure of Marks and ...

The sudden resignation of Peter Marks, M.D., Ph.D., from the FDA branch that regulates biological products for humans ...

Discover March 2025’s top biotech deals, featuring major collaborations in small molecules, bispecific antibodies and protein ...

Rod McGillis told Mike Martone in 2020 their Grade 9 girls would one day win the St. Peter Saints their first OFSAA gold medal. On Thursday the girls proved McGillis, who retired from teaching and ...

Plus Therapeutics shares are trading higher by 244% during Thursday's session. The company announced that the FDA accepted the name REYOBIQ for the company's lead asset. The ‘Trade of the Day ...

The overall quant rating is not an average of the factor grades listed. Instead, it gives greater weight to the metrics with the strongest predictive value.

In this article, we are going to take a look at where Akebia Therapeutics ... Start Investing in Stocks in 2025 and Beyond’ guide, Peter Gratton provides a list of 7 steps to lead the stock ...

BofA lowered the firm’s price target on United Therapeutics (UTHR) to $314 from $328 and keeps an Underperform rating on the shares. The firm thinks the challenges to owning United in 2025 are ...

The company will henceforth be known as Whitehawk Therapeutics, it announced Tuesday. Its stock ticker will be updated accordingly: As of Wednesday, it will trade as “WHWK” on the Nasdaq ...

Rasmus Hojlund says Manchester United legend Peter Schmeichel has provided him with invaluable support since he joined the club. The striker bagged his first goal of 2025 with a clinical finish to ...

Backyard Baseball making a comeback on mobile without ads triggered excitement among gamers. The official announcement hinted at a possible release date of March 27, coinciding with MLB Opening ...